Patent

G1/21 – EPO continues oral proceedings by videoconference in examination and opposition

Lloyd Palmer provides a short update on the EPO’s decision to continue oral proceedings by videoconference in examination and opposition during pendency of referral G1/21 You can read the EPO news item on G1/21 here. Making predictions within the global uncertainty of the past few years has been a risky business. From unpredictable US elections… Read more »

UK Government ‘call for views on AI & IP’ response

AA Thornton’s AI experts contributed to the UK government review of artificial intelligence and intellectual property and have been monitoring developments. Mike Jennings and LLoyd Palmer provide this summary of recent government progress The UK Government has published the responses it received to its 2020 “Call for views on AI and IP” and published its… Read more »

Lack of enablement in Amgen v Sanofi and Regeneron

Amgen v Sanofi and Regeneron: Broad antibody patents held invalid for lack of enablement in US Lack of enablement: A conclusion of lack of enablement means that the disclosure provided in the patent specification, at the time the application was filed, would not have taught one skilled in the art how to make and/or use the full… Read more »

Patenting in the Pandemic

Partner Dr. Lawrence King reflects on Patenting in the Pandemic and the importance of locking down innovation in troubled times in this article, first published in The Chemical Engineer. The importance of locking down innovation in troubled times TO MOST, A Poor Man’s Tale of a Patent, published in October 1850, remains one of Charles Dickens’ lesser-known… Read more »

UKIPO “Green Channel” – can the patent system encourage more innovation in green technologies?

Partners Mike Jennings and Alex Bone explore the UKIPO “Green Channel” At AA Thornton, our patent attorneys have a long history of assisting innovators seeking protection for a variety of green technology including solar technology, waste processing and wind turbines.  Some of our clients were kind enough to share their stories with us, and you… Read more »

Access to Intellectual Property (IP) Rights in a Time of Emergency – Patent Pools and Beyond

Access to Intellectual Property (IP) Rights in a Time of Emergency – Patent Pools and Beyond This article was first published in BioScience Today The pharmaceutical and healthcare industry is often accused of misusing IP to extend exclusivity and delay reasonably priced access to life saving technologies. The recent pandemic has focussed attention on the… Read more »

Patenting AI and computer simulation – an interview with Partner Mike Jennings

An interview with Mike Jennings of AA Thornton – Patenting AI and computer simulation Partner Mike Jennings is a regular speaker on patenting computer-implemented inventions (CIIs).  In this interview, we asked Mike for an update on European patenting of artificial intelligence and computer simulation. AA Thornton has a substantial practice protecting CIIs.  Clients include some… Read more »

Categories

Archives